vs
雅培(CLB)与RPC INC(RES)财务数据对比。点击上方公司名可切换其他公司
RPC INC的季度营收约是雅培的3.1倍($425.8M vs $138.3M)。雅培净利率更高(3.6% vs -0.7%,领先4.3%)。RPC INC同比增速更快(27.0% vs 7.0%)。RPC INC自由现金流更多($31.2M vs $5.0M)。过去两年RPC INC的营收复合增速更高(6.2% vs 3.3%)
雅培是一家总部位于美国伊利诺伊州阿伯特公园的跨国医疗保健企业,在全球医疗健康领域开展业务,主营诊断产品、营养健康产品、医疗器械,同时在美国境外销售医药产品,是全球知名的医疗健康提供商。
RPC集团是总部位于英国的企业,曾是欧洲规模最大的塑料包装供应商之一,总部坐落于北安普敦郡的拉什登。该公司此前在伦敦证券交易所上市,2019年被贝瑞全球集团收购,贝瑞全球集团又于2025年被安海斯包装收购。
CLB vs RES — 直观对比
营收规模更大
RES
是对方的3.1倍
$138.3M
营收增速更快
RES
高出20.0%
7.0%
净利率更高
CLB
高出4.3%
-0.7%
自由现金流更多
RES
多$26.2M
$5.0M
两年增速更快
RES
近两年复合增速
3.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $138.3M | $425.8M |
| 净利润 | $4.9M | $-3.1M |
| 毛利率 | 20.8% | 21.0% |
| 营业利润率 | 11.5% | -0.9% |
| 净利率 | 3.6% | -0.7% |
| 营收同比 | 7.0% | 27.0% |
| 净利润同比 | -33.2% | -124.0% |
| 每股收益(稀释后) | $0.11 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLB
RES
| Q4 25 | $138.3M | $425.8M | ||
| Q3 25 | $134.5M | $447.1M | ||
| Q2 25 | $130.2M | $420.8M | ||
| Q1 25 | $123.6M | $332.9M | ||
| Q4 24 | $129.2M | $335.4M | ||
| Q3 24 | $134.4M | $337.7M | ||
| Q2 24 | $130.6M | $364.2M | ||
| Q1 24 | $129.6M | $377.8M |
净利润
CLB
RES
| Q4 25 | $4.9M | $-3.1M | ||
| Q3 25 | $14.2M | $13.0M | ||
| Q2 25 | $10.6M | $10.1M | ||
| Q1 25 | $-154.0K | $12.0M | ||
| Q4 24 | $7.4M | $12.8M | ||
| Q3 24 | $11.7M | $18.8M | ||
| Q2 24 | $9.0M | $32.4M | ||
| Q1 24 | $3.2M | $27.5M |
毛利率
CLB
RES
| Q4 25 | 20.8% | 21.0% | ||
| Q3 25 | 22.0% | 25.1% | ||
| Q2 25 | 20.3% | 24.5% | ||
| Q1 25 | 19.5% | 26.7% | ||
| Q4 24 | 17.8% | 25.4% | ||
| Q3 24 | 20.5% | 26.7% | ||
| Q2 24 | 21.2% | 28.0% | ||
| Q1 24 | 19.3% | 26.8% |
营业利润率
CLB
RES
| Q4 25 | 11.5% | -0.9% | ||
| Q3 25 | 15.6% | 4.7% | ||
| Q2 25 | 11.7% | 3.7% | ||
| Q1 25 | 3.6% | 3.7% | ||
| Q4 24 | 11.0% | 3.1% | ||
| Q3 24 | 14.7% | 5.7% | ||
| Q2 24 | 12.3% | 9.7% | ||
| Q1 24 | 6.6% | 8.6% |
净利率
CLB
RES
| Q4 25 | 3.6% | -0.7% | ||
| Q3 25 | 10.6% | 2.9% | ||
| Q2 25 | 8.2% | 2.4% | ||
| Q1 25 | -0.1% | 3.6% | ||
| Q4 24 | 5.7% | 3.8% | ||
| Q3 24 | 8.7% | 5.6% | ||
| Q2 24 | 6.9% | 8.9% | ||
| Q1 24 | 2.5% | 7.3% |
每股收益(稀释后)
CLB
RES
| Q4 25 | $0.11 | $-0.02 | ||
| Q3 25 | $0.30 | $0.06 | ||
| Q2 25 | $0.22 | $0.05 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $0.15 | $0.06 | ||
| Q3 24 | $0.25 | $0.09 | ||
| Q2 24 | $0.19 | $0.15 | ||
| Q1 24 | $0.07 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $22.7M | $210.0M |
| 总债务越低越好 | $110.3M | — |
| 股东权益账面价值 | $266.0M | $1.1B |
| 总资产 | $584.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势,按日历期对齐
现金及短期投资
CLB
RES
| Q4 25 | $22.7M | $210.0M | ||
| Q3 25 | $25.6M | $163.5M | ||
| Q2 25 | $31.2M | $162.1M | ||
| Q1 25 | $22.1M | $326.7M | ||
| Q4 24 | $19.2M | $326.0M | ||
| Q3 24 | $21.5M | $276.9M | ||
| Q2 24 | $17.7M | $261.5M | ||
| Q1 24 | $14.9M | $212.2M |
总债务
CLB
RES
| Q4 25 | $110.3M | — | ||
| Q3 25 | $114.1M | — | ||
| Q2 25 | $124.6M | — | ||
| Q1 25 | $124.4M | — | ||
| Q4 24 | $126.1M | — | ||
| Q3 24 | $139.9M | — | ||
| Q2 24 | $147.6M | — | ||
| Q1 24 | $160.4M | — |
股东权益
CLB
RES
| Q4 25 | $266.0M | $1.1B | ||
| Q3 25 | $271.3M | $1.1B | ||
| Q2 25 | $261.3M | $1.1B | ||
| Q1 25 | $253.4M | $1.1B | ||
| Q4 24 | $246.6M | $1.1B | ||
| Q3 24 | $250.7M | $1.1B | ||
| Q2 24 | $240.3M | $1.1B | ||
| Q1 24 | $232.2M | $1.0B |
总资产
CLB
RES
| Q4 25 | $584.0M | $1.5B | ||
| Q3 25 | $591.4M | $1.5B | ||
| Q2 25 | $602.1M | $1.5B | ||
| Q1 25 | $591.5M | $1.3B | ||
| Q4 24 | $585.1M | $1.4B | ||
| Q3 24 | $600.5M | $1.3B | ||
| Q2 24 | $597.8M | $1.3B | ||
| Q1 24 | $597.8M | $1.3B |
负债/权益比
CLB
RES
| Q4 25 | 0.41× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 0.61× | — | ||
| Q1 24 | 0.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $7.9M | $61.9M |
| 自由现金流经营现金流 - 资本支出 | $5.0M | $31.2M |
| 自由现金流率自由现金流/营收 | 3.6% | 7.3% |
| 资本支出强度资本支出/营收 | 2.1% | 7.2% |
| 现金转化率经营现金流/净利润 | 1.61× | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | $52.9M |
8季度趋势,按日历期对齐
经营现金流
CLB
RES
| Q4 25 | $7.9M | $61.9M | ||
| Q3 25 | $8.5M | $46.5M | ||
| Q2 25 | $13.9M | $53.1M | ||
| Q1 25 | $6.7M | $39.9M | ||
| Q4 24 | $20.6M | $94.2M | ||
| Q3 24 | $13.1M | $70.7M | ||
| Q2 24 | $17.1M | $127.9M | ||
| Q1 24 | $5.5M | $56.6M |
自由现金流
CLB
RES
| Q4 25 | $5.0M | $31.2M | ||
| Q3 25 | $6.5M | $4.1M | ||
| Q2 25 | $10.4M | $10.0M | ||
| Q1 25 | $3.9M | $7.6M | ||
| Q4 24 | $17.4M | $53.7M | ||
| Q3 24 | $10.4M | $19.1M | ||
| Q2 24 | $14.3M | $52.9M | ||
| Q1 24 | $2.5M | $3.8M |
自由现金流率
CLB
RES
| Q4 25 | 3.6% | 7.3% | ||
| Q3 25 | 4.8% | 0.9% | ||
| Q2 25 | 8.0% | 2.4% | ||
| Q1 25 | 3.1% | 2.3% | ||
| Q4 24 | 13.4% | 16.0% | ||
| Q3 24 | 7.7% | 5.6% | ||
| Q2 24 | 10.9% | 14.5% | ||
| Q1 24 | 1.9% | 1.0% |
资本支出强度
CLB
RES
| Q4 25 | 2.1% | 7.2% | ||
| Q3 25 | 1.5% | 9.5% | ||
| Q2 25 | 2.7% | 10.2% | ||
| Q1 25 | 2.3% | 9.7% | ||
| Q4 24 | 2.5% | 12.1% | ||
| Q3 24 | 2.0% | 15.3% | ||
| Q2 24 | 2.2% | 20.6% | ||
| Q1 24 | 2.4% | 14.0% |
现金转化率
CLB
RES
| Q4 25 | 1.61× | — | ||
| Q3 25 | 0.60× | 3.59× | ||
| Q2 25 | 1.31× | 5.23× | ||
| Q1 25 | — | 3.31× | ||
| Q4 24 | 2.78× | 7.38× | ||
| Q3 24 | 1.12× | 3.76× | ||
| Q2 24 | 1.90× | 3.95× | ||
| Q1 24 | 1.72× | 2.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLB
| Services | $107.0M | 77% |
| Products | $31.3M | 23% |
RES
| Technical Service | $405.2M | 95% |
| Other | $8.8M | 2% |
| Nitrogen | $6.6M | 2% |